Norway· NO-ID_AA53AB01-009A-45FA-8B24-93C365B7E0A9
Aldactone
A potassium canrenoate product containing kanrenoatkalium, registered in Norway by Esteve Pharmaceuticals GmbH. The same ATC class is registered in 9 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Potassium canrenoate is registered in 9 of 19 countries.
Countries holding a registration under ATC C03DA02 (potassium canrenoate), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Potassium canrenoate · ATC C03DA02
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Germany
- Italyprice
- Japan
- Norwayprice
- Polandprice
- United Kingdom
Price per daily dose
What a daily dose of potassium canrenoate costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Potassium canrenoate · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- IT Italy$0.82
The record
At a glance
FEST (Norway)- Active substance
- Kanrenoatkalium
- Manufacturer
- Esteve Pharmaceuticals GmbH
- Country
- Norway (NO)
- ATC code
- C03DA02
- ATC class
- Potassium canrenoate
- Defined daily dose
- 0.4 g, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_AA53AB01-009A-45FA-8B24-93C365B7E0A9
- no_varenummer36062710 x 10
- gtin4150024712932
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for potassium canrenoate.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Potassium canrenoate · interactions on record
5 records
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Potassium canrenoate in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7d1ca63e-c33b-4d69-b843-4fc60894427a GET /v1/drugs/7d1ca63e-c33b-4d69-b843-4fc60894427a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Kanrenoatkalium",
"merkevare_id": "ID_AA53AB01-009A-45FA-8B24-93C365B7E0A9",
"name_form_strength": "Aldactone inj, oppl 200 mg/10 ml",
"prescription_group": "C"
}See everything about potassium canrenoate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.